KS BIOMEDIX LTD has a total of 67 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are REMD BIOTHERAPEUTICS INC, SYLVAN PHARMACEUTICALS PTY LTD and IMCLONE LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Australia | 6 | |
#5 | Canada | 4 | |
#6 | United States | 4 | |
#7 | China | 3 | |
#8 | Mexico | 3 | |
#9 | Bulgaria | 2 | |
#10 | Brazil | 2 | |
#11 | Czechia | 2 | |
#12 | Croatia | 2 | |
#13 | Indonesia | 2 | |
#14 | Israel | 2 | |
#15 | Norway | 2 | |
#16 | Poland | 2 | |
#17 | South Africa | 2 | |
#18 | Hungary | 1 | |
#19 | Yugoslavia (Serbia and Montenegro) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Harrison Peter John | 26 |
#2 | Chayen Joseph | 11 |
#3 | Bitensky Lucille | 8 |
#4 | Tan Kim Sze | 7 |
#5 | Harrison Peter | 4 |
#6 | Harrison P J | 2 |
#7 | Harrison Peter J | 2 |
#8 | Bitensky L | 1 |
#9 | Bitensky Liculle | 1 |
#10 | Chayen J | 1 |
Publication | Filing date | Title |
---|---|---|
GB0303452D0 | Method | |
GB0113366D0 | Composition | |
GB0031284D0 | High affinity antibodies | |
GB0030196D0 | Enzyme-assisted cell death | |
GB0017028D0 | Peptides and their therapeutic use | |
GB9926529D0 | Targeting agents | |
CZ2001657A3 | Bifunctional antibodies, radiolabelled substance and product formed by antibodies as well as their use for preparing a preparation for treating cancer or for diagnostic methods | |
CZ2001658A3 | High-affinity monoclonal antibody, polynucleotide molecule and cloning vector | |
GB9918051D0 | Antibodies | |
GB9914057D0 | Antibody therapy | |
GB9819411D0 | Antibodies | |
GB9818915D0 | Antibodies | |
US6471963B1 | Purified antigenic material and its use in the diagnosis and treatment of diabetes | |
GB9425487D0 | Osteoarthritis treatment | |
US5763479A | Naphthoquinone derivatives for the treatment of chronic inflammation | |
WO9201058A1 | Hybridomas | |
GB9104498D0 | Antibody | |
EP0401271A1 | Antigen against diabetes |